Background The effect of early vasopressin initiation on clinical outcomes in patients with
septic shock is uncertain. A systematic review and meta-analysis was performed to evaluate …

Purpose Vasopressin has become an important vasopressor drug while treating a critically
ill patient to maintain adequate mean arterial pressure. Diabetes insipidus (DI) is a rare …

Background vasopressin is commonly used as a second-line vasopressor for patients with
septic shock, but the optimal timing of initiation is uncertain. This study was designed to …

Background Vasopressin is often utilized for hemodynamic support in patients with septic
shock. However, the most appropriate patient to initiate therapy in is unknown. This study …

Purpose Delays in achieving target mean arterial pressure (MAP) are associated with
increased morbidity and mortality in patients with septic shock. This trial was conducted to …

Background Septic shock is a leading cause of death in intensive care units (ICUs), with
short-term mortality rates of 35–40%. Vasopressin (AVP) is a second-line vasoactive agent …

Purpose: The aim of the study is to determine whether initiating vasopressin earlier in septic
shock reduces organ dysfunction and in-hospital all-cause mortality. Methods: This …

Background In septic shock, vasopressors aim to improve tissue perfusion and prevent
persistent organ dysfunction, a characteristic of chronic critical illness (CCI). Adjunctive …

Background The aim of this study was to evaluate the effects and safety of vasopressin
receptor agonists in patients with septic shock. Methods PubMed, EMBASE, and Cochrane …

Background: Vasopressor plays a crucial role in septic shock. However, the time for
vasopressor initiation remains controversial. We conducted a systematic review and meta …